Yahoo Web Search

Search results

    • AbbVie Completes Acquisition of Landos Biopharma

      KTBS Shreveport· 3 days ago

      With the completion of the acquisition, Landos is now part of AbbVie. Landos' lead investigational asset is NX-13, a first-in-class, oral NLRX1 agonist (a member of the NOD-like receptor family ...

    • Colorado moves first on AI regulation

      Colorado moves first on AI regulation

      Politico· 4 days ago

      Newborns of mothers who speak one language respond differently to sound than newborns of bilingual mothers, according to a study published today in...